Safe administration of bevacizumab combination chemotherapy for the patients with recurrent cervical cancer after pelvic radiotherapy: Two case reports

In Japan, bevacizumab has not been proven either effective or safe for the treatment of recurrent cervical cancer. The present study reported two cases in which bevacizumab combination chemotherapy was safely administered for recurrent cervical cancer following pelvic radiotherapy. Case 1 was a 62-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Tadahiro, Takeshita, Ryosuke, Mukaida, Rika, Takatori, Eriko, Nagasawa, Takayuki, Omi, Hideo, Sugiyama, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083409/
https://www.ncbi.nlm.nih.gov/pubmed/30101016
http://dx.doi.org/10.3892/mco.2018.1642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083409/
https://www.ncbi.nlm.nih.gov/pubmed/30101016
http://dx.doi.org/10.3892/mco.2018.1642

Ejemplares similares